META vs PFE: Which Is the Better Buy?
Side-by-side comparison of Meta Platforms, Inc. and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-11.
Meta Platforms, Inc. · Communication Services
$611.40
+12.9% upside to fair value
High Conviction
Grade A-
VS
Pfizer Inc. · Healthcare
$26.91
+30.1% upside to fair value
Med Conviction
Grade B+
QuantHub Verdict
PFE has more upside to fair value
(+30.1%).
PFE trades at a lower forward P/E
(9.5x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
META |
PFE |
| Current Price |
$611.40 |
$26.91 |
| Fair Value Estimate |
$690.00 |
$35.00 |
| Upside to Fair Value |
+12.9%
|
+30.1%
|
| Market Cap |
$1,541.3B |
$153.0B |
| Forward P/E |
23.0x
|
9.5x
|
| EV / EBITDA |
18.0x
|
13.8x
|
| Price / Sales |
7.7x
|
2.4x
|
| Price / FCF |
33.4x
|
16.8x
|
| Revenue Growth YoY |
+22.2%
|
-1.6%
|
| Gross Margin |
82.0%
|
70.3%
|
| Operating Margin |
41.4%
|
24.7%
|
| Return on Equity |
30.6%
|
9.0%
|
| Dividend Yield |
0.4% |
6.4% |
| FCF Yield |
3.0%
|
5.9%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Meta Platforms operates the world's largest social media ecosystem (Facebook, Instagram, WhatsApp, Threads) reaching 3.3B+ daily users, generating $201B in revenue predominantly from digital advertising. The company's 82% gross margins and AI-powered ad targeting create an extraordinarily profitable core business. Trading at its 5-year P/E low of 25.5x despite 22% revenue growth, META is cheap on…
Pfizer remains the world's largest traditional pharmaceutical company by non-COVID revenue, generating $62.6B in 2025 sales across oncology, cardiovascular, immunology, and vaccines. The stock trades at a P/S of 2.44x, still well below the 5-year median of 3.10x, driven by post-COVID revenue normalization, a $17-18B patent cliff spanning 2026-2028, and $61.6B in acquisition-related debt from Seag…
Accumulation Zones
| Metric |
META |
PFE |
| Zone Low |
$520.00 |
$25.00 |
| Zone High |
$590.00 |
$29.00 |
| In Buy Zone? |
No
|
Yes
|